COPYRIGHT © DIGITAL JOURNAL INC. Sitemaps: XML / News. Digital Journal is not responsible for the content of external sites. Read more about our external linking
DelveInsight’s ‘WHIM Syndrome Market Insights, Epidemiology, and Market Forecast—2032’ report deliver an in-depth understanding of the WHIM Syndrome, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
The WHIM Syndrome market report provides current treatment practices, emerging drugs, and their market share of the individual therapies, current and forecasted WHIM Syndrome symptoms market size from 2019 to 2032 segmented by seven major markets. The report also covers current WHIM Syndrome symptoms treatment practice/algorithm and unmet medical needs to curate the best opportunities. It assesses the underlying potential of the market.
Some of the Key Facts of the Whim Syndrome Market:
●Japan had ~ 30 prevalent cases of WHIM Syndrome in 2021.
●The 2021 annual report of the French Chronic Neutropenia Registry reported that the number of WHIM patients in France was 15 (Registre Français des neutropénies Chroniques & sévères, 2021).
Got queries? Click here to know more about the Whim Syndrome Market Landscape
Whim Syndrome Overview
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is an ultra-rare and difficult-to-diagnose primary immunodeficiency disease. In almost all patients of WHIM syndrome, the disease is caused by “gain-of-function” mutations in the single gene that encodes for the CXCR4 receptor. WHIM syndrome is a congenital immune deficiency with characteristic clinical features that include: susceptibility to human papillomavirus (HPV) infection-induced warts, condyloma acuminata, and carcinomas; neutropenia, B cell lymphopenia, and hypogammaglobulinemia related recurrent infections; and bone marrow myelokathexis characterized by myeloid hyperplasia and apoptosis. WHIM syndrome is diagnosed by clinical findings like neutropenia, recurrent infections, warts, lymphopenia, bone marrow biopsy (myelokathexis), and CXCR4 gene mutation. However, in real-time clinical practice, timely and accurate diagnosis of WHIM syndrome is challenging, given the heterogeneity and specific nature of the clinical presentation of the disease (warts, hypogammaglobulinemia, and neutropenia).
Whim Syndrome Epidemiology Insights
●According to the National Organization for Rare Disorders (NORD, 2022), WHIM syndrome is an extremely rare disease, with about 100 cases reported in the various medical literature. Another research study states that there are around 105 probable WHIM syndrome patients (searched for diagnosis of myelokathexis or WHIM syndrome or a germline CXCR4 mutation) mined from the various biomedical literature (Heusinkveld et al., 2019).
●In 2021, the total prevalent cases of WHIM Syndrome were the highest in the US, with around 70 cases, and lowest in Spain, with around 10 cases.
●There were approximately 30 males and 40 females affected by WHIM Syndrome in the United States in 2021, and it is estimated that the prevalence will increase and reach up to 50 males and 75 females by 2032.
Whim Syndrome Epidemiology Segmentation
●Total Whim Syndrome diagnosed cases
●Total Whim Syndrome age-specific cases
●Total Whim Syndrome gender-specific cases
Whim Syndrome Market Outlook
The report’s WHIM Syndrome market outlook helps to understand the historical, current better, and forecasted WHIM Syndrome market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the WHIM Syndrome market trend of each marketed drug and early-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to view the market at first sight. According to DelveInsight, the WHIM Syndrome market in 7MM is expected to grow steadily during the study period 2019–2032.
Learn more by requesting for sample @ Whim Syndrome Market
Table of Contents
1. Key Insights
2. Report Introduction
3. Executive Summary of Whim Syndrome
4. Disease Background and Overview
5. Epidemiology and patient population
6. The United States
7. EU 5
8. Whim Syndrome Emerging Therapies
9. Whim Syndrome Market Outlook
10. Market Access and Reimbursement of Therapies
11. Appendix
12. Whim Syndrome Report Methodology
13.DelveInsight Capabilities
14. Disclaimer
Click here to read more about Whim Syndrome Market Trends
Related Reports
Whim Syndrome Pipeline Insights,2022
Whim Syndrome Pipeline Insights, 2022″ report by DelveInsight outlays comprehensive insights of the present clinical development scenario and growth prospects across the Whim Syndrome market. A detailed picture of the Whim Syndrome pipeline landscape is provided, which includes the disease overview and Whim Syndrome treatment guidelines. The assessment part of the report embraces in-depth Whim Syndrome commercial assessment and clinical assessment of the Whim Syndrome pipeline products from the pre-clinical developmental phase to the marketed phase. In the report, a detailed description of the drug is proffered including mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Whim Syndrome collaborations, licensing, mergers and acquisition, funding, designations, and other product-related details.
Related Reports
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com